J&J beats in Q4 with in line guidance; so why is its stock falling?
Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading
Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading
JHVEPhoto Intra-Cellular Therapies (NASDAQ:ITCI) edged higher by 0.6% as Johnson & Johnson (JNJ) said it
mohd izzuan Johnson & Johnson (NYSE:JNJ) traded flat in the premarket on Wednesday after the
alvarez/E+ via Getty Images Genmab A/S (GMAB) Wednesday reported that worldwide net trade sales of
Johnson & Johnson press release (NYSE:JNJ): Q4 Non-GAAP EPS of $2.04 beats by $0.02. Revenue
Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4
Grandbrothers Johnson & Johnson (NYSE:JNJ) announced Tuesday that the U.S. FDA approved a supplemental New
mapo Odyssey Therapeutics (ODTX), which is developing treatments for inflammatory bowel disease, has filed for